Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer

• Главные авторы: Yongbao Wei (Автор), Ruochen Zhang (Автор), Dewen Zhong (Автор), Zhensheng Chen (Автор), Gen Chen (Автор), Minggen Yang (Автор), Le Lin (Автор), Tao Li (Автор), Liefu Ye (Автор), Lili Chen (Автор), Qingguo Zhu (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Whether neoadjuvant therapy confers a survival benefit in advanced prostate cancer (PCa) remains uncertain. The primary endpoints of previous retrospective and phase II clinical studies that used neoadjuvant therapy, including androgen deprivation therapy combined with new-generation androgen recept...